Home/Filings/4/0001209191-23-017342
4//SEC Filing

Session R.A. II 4

Accession 0001209191-23-017342

CIK 0001806310other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 7:38 PM ET

Size

10.0 KB

Accession

0001209191-23-017342

Insider Transaction Report

Form 4
Period: 2023-03-06
Session R.A. II
DirectorPresident and CEO10% Owner
Transactions
  • Other

    Common Stock

    2023-03-06+251,2969,420,842 total
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2023-03-06199,5000 total
    Exercise: $1.95Exp: 2032-11-10Common Stock (199,500 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    141,090
  • Common Stock

    (indirect: See footnote)
    141,090
Footnotes (7)
  • [F1]Represents Reporting Person's annual incentive compensation for 2021 performance awarded in the discretion of the compensation committee of the Issuer's board of directors (the "RSU Award"). The RSU Award replaced a prior stock option award of 199,500 shares of similar value that was canceled effective March 6, 2023.
  • [F2]Each share is represented by an RSU. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs are fully vested.
  • [F3]In connection with the Reporting Person's separation from the Issuer, the Reporting Person forfeited 21,374 unvested shares pursuant to a restricted stock award.
  • [F4]The securities are held by RA Session II, as Trustee of the Session 2020 Annuity Trust I.
  • [F5]The securities are held by RA Session II, as Trustee of the Session 2020 Annuity Trust II.
  • [F6]Prior to the cancellation of this option, 25% of the total number of shares underlying the option were to vest and become exercisable on November 10, 2023 and the remainder were to vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
  • [F7]This option was canceled by mutual agreement of the Issuer and the Reporting Person. The Reporting Person received the RSU Award in exchange for the cancellation of this option.

Issuer

Taysha Gene Therapies, Inc.

CIK 0001806310

Entity typeother

Related Parties

1
  • filerCIK 0001701846

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 7:38 PM ET
Size
10.0 KB